ABSTRACT The antitumor drug cis-diamminedichloroplatinum(II) dramatically alters the sequence-specific cleavage of the bleomycin Ar-iron(11)-02 system. Preferred bleomycin cleavage sites adjacent to oligo(dG) regions on two restriction fragments of plasmid pBR322 DNA were masked by pretreatment with cis-diamminedichloroplatinum(II). trans-Diamminedichloroplatinum-(II), which is inactive as an antitumor drug, showed similar but not identical behavior. The DNA-cleaving activity of bleomycin was substantially modified by cis-diamminedichloroplatinum(11), and a number of specific new cutting sites in guanine-rich parts of the sequence were activated by both isomers of the platinum complex. The -sults further emphasize the possibility that the synergism found when cis-diamminedichloroplatinum(II) and bleomycin are used in combination chemotherapy may be due to interactions at the level of DNA-drug binding.
Bleomycin and cis-diamminedichloroplatinum(II) (cis-DDP) ( Fig.  1 ) are used in combination chemotherapy to treat malignant melanoma (2) , head-neck carcinoma (3) , and testicular carcinoma (4) . The two drugs exhibit synergism in the clinical management of head and neck cancer (5) . The biological target for both cis-DDP (6) and bleomycin (7) is believed to be DNA.
Bleomycin cleaves double-stranded DNA specifically at 5'-*3' G-C and G-T sequences in the presence of ferrous ion and molecular oxygen (1, (8) (9) (10) (11) (12) , and the anticancer activity of this glycopeptide antibiotic is related to DNA strand scission. cis-DDP, on the other hand, binds covalently to DNA. Attachment of cis-DDP to poly(dG) regions through intrastrand crosslinking of guanosine N7 atoms is thought to be responsible for its various biological activities (13) (14) (15) (16) (17) . Previously we showed that the intercalating drug ethidium bromide changes the nuclease-sensitive DNA-binding sites of cis-DDP (15) and that ethidium bromide, distamycin A, and actinomycin D modify the sequence-specific cleavage mode of bleomycin (18 (14) . The DNA samples were collected once again by precipitation, washed three times with cold 75% ethanol, and subjected to electrophoresis together with the Maxam-Gilbert sequencing fragments (20) on a 10% or 15% polyacrylamide/7 M urea slab gel.
RESULTS AND DISCUSSION
The two restriction fragments used in this work start from different 5' end points on pBR322 DNA but terminate at the same 3' end. Their sequences in the regions of interest are given in Fig. 2 . The 165-bp fragment was allowed to react with various concentrations of cis-and trans-DDP and the bleomycin concentration was also varied. For the 327-bp piece, only cis-DDP was used to check whether similar interactions occur farther up the DNA nucleotide chain.
Abbreviations: cis-and trans-DDP, cis-and trans-diamminedichloroplatinum(II); D/N, mole ratio of drug to nucleotide concentrations; bp, base pair(s). * To whom reprint requests should be addressed. 6795 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 1-4) to identify the bleomycin cleavage fragments. Cleavage of 5'-end-labeled DNA with bleomycin is known to produce a major fragment that runs slightly faster than fragments of equal base length created by the Maxam-Gilbert sequencing reactions and a minor-fragment with mobility indistinguishable -from that of the Maxam-Gilbert generated pieces (1, 8) . We confirm this observation, which is especially apparent for short, rapidly migrating fragments (Fig.  3) . Control digestions, performed in the absence of any added platinum reagent (Fig. 3, lanes 5 and 14; Fig. 4, lane 6) , reveal the known propensity of bleomycin in the presence of Fe(II) and oxygen to cleave double-stranded DNA preferentially at 5'-*3' G-C and G-T sequences. Strong bands appear at positions T16, C30, and C42 in the 165-bp DNA and at positions C33, T36, C41, T53, T57, and C59 in the 327-bp DNA control lanes (Figs.  2-4) . Interestingly, strong bands also appear at selected purine bases adjacent to the 3' side of guanosine: A26 and G49 for the 165-bp fragment and G48 for the 327-bp fragment. Although 5'-)3' G-A-and G-G-specific cleavages have been previously identified-forbleomycin A2-Fe(II) (10), they usually constitute only a small minority of the cutting sites. In the present case BLM4ftw-DDPI tI [5'-327] (2829) DDP prior to the addition of bleomycin, dramatic changes were observed in the sequence-specific cleavage patterns (Figs. 2-4 ). Many more short cleavage products appeared in lanes containing bleomycin-digested DNA that had previously been allowed to react with either cis-or trans-DDP at D/N = 0.041, corresponding to 0.013 bound platinum-atom per nucleotide.
Specifically, strong bands appeared at positions C8, G1o, CI1, A28, and C32 of the 165-bp DNA that were either weak or absent from the control lanes. Cleavage at C17 along the 165-bp fragment was enhanced by cis-but not trans-DDP. Pretreatment of DNA with low D/N of either cis-or trans-DDP also masked the preferred bleomycin cleavage at G49, the second nucleotide of the (dG)5 sequence in the 165-bp DNA, and a higher D/N of cis-DDP produced the same effect at the G-G- G-G-G-G-T sequence in the 327-bp piece. Increasing the formal D/N resulted in many fewer bleomycin cleavage products appearing in lanes corresponding to DNA pretreated with cis-DDP (Fig. 3) . We attribute this effect to enhanced cleaving of DNA by bleomycin between the point of platinum attachment and the 5' end label. Moreover, the bands that did appear on the gel were smeared, indicating that some platinum remained on the DNA despite treatment with cyanide. This cyanide-resistant fraction of cis-DDP bound to DNA, especially at high D/N ratios, has been observed and discussed previously (14) . Similar behavior was not exhibited in experiments with the trans isomer.
Recent NMR studies indicate that cis-DDP forms intrastrand crosslinks between N7 atoms of adjacent deoxyguanosine residues in the sequences [d(A-G-G-C-C-T)]2 (24) and (25) 
